The pharmaceutical industry is aggressively evolving, with substantial demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To address this demand, US-based manufacturing services are stepping forward. These companies offer a detailed suite of services, from rese